Literature DB >> 19725787

Improving the diagnosis of acute hepatitis C virus infection with expanded viral load criteria.

Barbara H McGovern1, Christopher E Birch, Melinda J Bowen, Laura L Reyor, Ellen H Nagami, Raymond T Chung, Arthur Y Kim.   

Abstract

BACKGROUND: The diagnosis of acute hepatitis C virus (HCV) infection is imprecise because antibody testing does not differentiate between acute and chronic infection. Although virologic features, such as viral load fluctuations and low levels of viremia, have been noted to be characteristic of acute HCV infection, these parameters have not been used for diagnosis.
METHODS: We validated the use of these novel parameters (ie, viral load fluctuations >1 log and HCV RNA levels <100,000 IU/mL) in a cohort of acute HCV seroconverters. We then applied standard diagnostic criteria for acute HCV infection in a cohort of high-risk injection drug users entering prison with suspected acute HCV infection (n=37). We subsequently assessed whether these novel virologic parameters, measured serially over a 10-week period, could enhance the diagnosis of acute infection.
RESULTS: Low-level viremia and viral load fluctuations were highly prevalent in our cohort of acute seroconverters (81% and 86%, respectively), whereas low-level viremia occurred in only 13% of control patients with chronic infection. With use of standard criteria, 37 inmates received a diagnosis of acute HCV infection. Among the 35 patients with HCV RNA detectable at baseline, we found low-level viremia to be highly prevalent (n=27; 77%); among patients with a minimum of 2 HCV RNA samples, we demonstrated viral fluctuations in more than one-third (n=9; 36%).
CONCLUSIONS: The diagnosis of acute infection in HCV-seropositive patients is strengthened by the use of virologic parameters that are uncommon in chronic disease. Viral load fluctuations and low levels of HCV RNA should be incorporated into standard diagnostic criteria.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19725787      PMCID: PMC2741541          DOI: 10.1086/605561

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  37 in total

1.  Natural course of acute hepatitis C: a long-term prospective study.

Authors:  T Santantonio; E Sinisi; A Guastadisegni; C Casalino; M Mazzola; A Gentile; G Leandro; G Pastore
Journal:  Dig Liver Dis       Date:  2003-02       Impact factor: 4.088

2.  Diagnosis, management, and treatment of hepatitis C.

Authors:  Doris B Strader; Teresa Wright; David L Thomas; Leonard B Seeff
Journal:  Hepatology       Date:  2004-04       Impact factor: 17.425

3.  Treatment of acute hepatitis C with interferon alfa-2b.

Authors:  E Jaeckel; M Cornberg; H Wedemeyer; T Santantonio; J Mayer; M Zankel; G Pastore; M Dietrich; C Trautwein; M P Manns
Journal:  N Engl J Med       Date:  2001-11-15       Impact factor: 91.245

4.  Fluctuation of serum HCV-RNA levels in untreated blood donors with chronic hepatitis C virus infection.

Authors:  I K Kuramoto; T Moriya; V Schoening; P V Holland
Journal:  J Viral Hepat       Date:  2002-01       Impact factor: 3.728

5.  Sequential serum hepatitis C viral RNA levels longitudinally assessed by branched DNA signal amplification.

Authors:  S C Gordon; P J Dailey; A L Silverman; B A Khan; V P Kodali; J C Wilber
Journal:  Hepatology       Date:  1998-12       Impact factor: 17.425

6.  Fluctuations in viral load (HCV RNA) are relatively insignificant in untreated patients with chronic HCV infection.

Authors:  T T Nguyen; A Sedghi-Vaziri; L B Wilkes; T Mondala; P J Pockros; K L Lindsay; J G McHutchison
Journal:  J Viral Hepat       Date:  1996-03       Impact factor: 3.728

7.  Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance.

Authors:  J Tilman Gerlach; Helmut M Diepolder; Reinhart Zachoval; Norbert H Gruener; Maria-Christina Jung; Axel Ulsenheimer; Winfried W Schraut; C Albrecht Schirren; M Waechtler; M Backmund; Gerd R Pape
Journal:  Gastroenterology       Date:  2003-07       Impact factor: 22.682

8.  Hepatitis C virus seroconversion among young injection drug users: relationships and risks.

Authors:  Judith A Hahn; Kimberly Page-Shafer; Paula J Lum; Philippe Bourgois; Ellen Stein; Jennifer L Evans; Michael P Busch; Leslie H Tobler; Bruce Phelps; Andrew R Moss
Journal:  J Infect Dis       Date:  2002-11-04       Impact factor: 5.226

9.  Spontaneous viral clearance in patients with acute hepatitis C can be predicted by repeated measurements of serum viral load.

Authors:  Harald Hofer; Thomas Watkins-Riedel; Oskar Janata; Edward Penner; Heidemarie Holzmann; Petra Steindl-Munda; Alfred Gangl; Peter Ferenci
Journal:  Hepatology       Date:  2003-01       Impact factor: 17.425

10.  Drug-induced liver injury.

Authors:  Neil Kaplowitz
Journal:  Clin Infect Dis       Date:  2004-03-01       Impact factor: 9.079

View more
  40 in total

Review 1.  Reactivation of hepatitis B virus and hepatitis C virus in patients with cancer.

Authors:  Harrys A Torres; Marta Davila
Journal:  Nat Rev Clin Oncol       Date:  2012-01-24       Impact factor: 66.675

Review 2.  Treatment of acute HCV infection.

Authors:  Jason Grebely; Gail V Matthews; Gregory J Dore
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-03-22       Impact factor: 46.802

3.  A "one-two punch" leading to hepatitis C seroconversion.

Authors:  Ellen H Nagami; Arthur Y Kim; Christopher E Birch; Melinda J Bowen; Barbara H McGovern
Journal:  Clin Infect Dis       Date:  2010-12-28       Impact factor: 9.079

Review 4.  Adaptive immunity to the hepatitis C virus.

Authors:  Christopher M Walker
Journal:  Adv Virus Res       Date:  2010       Impact factor: 9.937

5.  Inhibition of Hepatitis C Virus Replication Induced by Chemotherapy: A Prospective Observational Study.

Authors:  Jeff Hosry; Georgios Angelidakis; Ahmed Kaseb; Ying Jiang; Harrys A Torres
Journal:  Clin Infect Dis       Date:  2018-10-30       Impact factor: 9.079

6.  Evaluation of the Aptima HCV Quant Dx Assay Using Serum and Dried Blood Spots.

Authors:  Jenna Weber; Malaya K Sahoo; Nathaniel Taylor; Run-Zhang Shi; Benjamin A Pinsky
Journal:  J Clin Microbiol       Date:  2019-03-28       Impact factor: 5.948

7.  The effect of transcatheter arterial chemoembolization on hepatitis C viremia.

Authors:  Parag Mahale; Ahmed Kaseb; Marta Davila; Harrys A Torres
Journal:  Oncologist       Date:  2012

8.  Plasma interferon-gamma-inducible protein-10 (IP-10) levels during acute hepatitis C virus infection.

Authors:  Jason Grebely; Jordan J Feld; Tanya Applegate; Gail V Matthews; Margaret Hellard; Alana Sherker; Kathy Petoumenos; Geng Zang; Ineke Shaw; Barbara Yeung; Jacob George; Suzy Teutsch; John M Kaldor; Vera Cherepanov; Julie Bruneau; Naglaa H Shoukry; Andrew R Lloyd; Gregory J Dore
Journal:  Hepatology       Date:  2013-05-08       Impact factor: 17.425

Review 9.  Estimating acute viral hepatitis infections from nationally reported cases.

Authors:  R Monina Klevens; Stephen Liu; Henry Roberts; Ruth B Jiles; Scott D Holmberg
Journal:  Am J Public Health       Date:  2014-01-16       Impact factor: 9.308

10.  How I treat hepatitis C virus infection in patients with hematologic malignancies.

Authors:  Harrys A Torres; George B McDonald
Journal:  Blood       Date:  2016-07-21       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.